2015
DOI: 10.1016/j.phrs.2015.01.005
|View full text |Cite
|
Sign up to set email alerts
|

The current challenges for pancreas transplantation for diabetes mellitus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0
2

Year Published

2015
2015
2023
2023

Publication Types

Select...
5
2
2

Relationship

0
9

Authors

Journals

citations
Cited by 10 publications
(6 citation statements)
references
References 121 publications
(126 reference statements)
0
4
0
2
Order By: Relevance
“…It improved transplanted islet survival in NOD mice, especially when combined with antigen-based therapy [51], as described in another section. A major limitation of clinical islet transplantation is that the majority of islets die soon after transplantation due to a combination of factors; most notably hypoxia and an acute inflammatory response [52][53][54]. In studies with human cells, we demonstrated that GABA markedly reduced islet-cell apoptosis in culture, and stimulated insulin production [34,55].…”
Section: Studies In Humansmentioning
confidence: 90%
“…It improved transplanted islet survival in NOD mice, especially when combined with antigen-based therapy [51], as described in another section. A major limitation of clinical islet transplantation is that the majority of islets die soon after transplantation due to a combination of factors; most notably hypoxia and an acute inflammatory response [52][53][54]. In studies with human cells, we demonstrated that GABA markedly reduced islet-cell apoptosis in culture, and stimulated insulin production [34,55].…”
Section: Studies In Humansmentioning
confidence: 90%
“…Pancreas transplantation is an effective method for the treatment of end-stage DM. [11][12][13] The difficulty of pancreas transplantation is mainly due to the anatomical and physiological characteristics of the pancreas itself. The pancreatic blood supply and structure are complicated by the multiple blood vessels involved.…”
Section: Discussionmentioning
confidence: 99%
“…El riesgo de muerte después de un trasplante de islotes es extremadamente bajo. En términos de malignidad, el registro CITR destaca pacientes con tumores basocelulares de piel o carcinoma de células escamosas, con una tasa global de 2,3%, probablemente resultante de la inmunosupresión crónica 66 .…”
Section: Riesgos Asociados Al Trasplante De Islotesunclassified